Adil Doganay Duru

Company: Glycostem Therapeutics

Job title: Director of Business Development

Seminars:

Industry Leader’s Fireside Chat: Discussing Present Advancements & Challenges in the Natural Killer Space to Envision the Future of NK Therapy 8:30 am

Discussing key advancements in the NK space to highlight the therapeutic potential of NK biology Sharing the latest findings in NK therapy and what this means for this field What are the biggest hurdles in this space that still need to be overcome?Read more

day: Day 1 AM

Discussing Strategies to Target & Overcome the Tumor Microenvironment 11:00 am

Understanding HLA-G and HLA-E mechanisms employed by tumors to suppress NK cells Discussing armoring approaches like receptor modifications and expression of membrane bound cytokinesRead more

day: Day 1 - Track A - AM

Panel Discussion: Exploring Current & Future Opportunities in Entering the Autoimmune Field as an NK Developer 9:00 am

What makes NK applications to the autoimmune space so exciting? Discussing recent advancements that showcase the promise of NK based therapy in autoimmune disease  Evaluating the main hurdles in expanding NKs to the autoimmune space Why is there more funding in autoimmunity than oncology?Read more

day: Pre-Conference Focus Day